Sign in

No link between Covid vaccine, deaths: Centre

ICMR and NCDC have been working together to understand the causes behind sudden unexplained deaths, especially in young adults between the ages of 18 and 45 years.

Published on: Jul 3, 2025, 06:36:05 IST
By , New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

The matter of sudden unexplained deaths in the country post-Covid 19 has been investigated through several agencies in the country that have conclusively established there is no direct link between Covid 19 vaccination and the reports of sudden deaths in the country, said Union ministry of health and family welfare in a statement on Wednesday. The ministry urged citizens to go only by the scientific evidence at hand.

ICMR and NCDC have been working together to understand the causes behind sudden unexplained deaths, especially in young adults between the ages of 18 and 45 years. (REUTERS)
ICMR and NCDC have been working together to understand the causes behind sudden unexplained deaths, especially in young adults between the ages of 18 and 45 years. (REUTERS)

“Studies by the Indian Council of Medical Research (ICMR) and National Centre for Disease Control (NCDC) affirm that COVID-19 vaccines in India are safe and effective, with extremely rare instances of serious side effects. Sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions, and post-COVID complications,” read the health ministry statement.

On Tuesday, Karnataka chief minister Siddaramaiah alleged that the hastily approved and distributed Covid vaccines could also be a reason for sudden deaths. In a post on X, he wrote that more than 20 people had died of heart attacks in the past one month alone in the Hassan district of the state.

ICMR and NCDC have been working together to understand the causes behind sudden unexplained deaths, especially in young adults between the ages of 18 and 45 years. To explore this, two complementary studies were undertaken using different research approaches—one based on past data and another involving real-time investigation.

The first study, conducted by ICMR’s National Institute of Epidemiology (NIE), was titled “Factors associated with unexplained sudden deaths among adults aged 18-45 years in India – A multicentric matched case–control study.” This study was carried out from May to August 2023 across 47 tertiary care hospitals in 19 states and Union Territories. It looked at individuals who appeared to be healthy but died suddenly between October 2021 and March 2023. The findings have conclusively shown that COVID-19 vaccination does not increase the risk of unexplained sudden death in young adults, said the health ministry.

The second study, titled “Establishing the cause in sudden unexplained deaths in young,” is currently being conducted by the All India Institute of Medical Sciences (AIIMS), New Delhi with funding and in collaboration with ICMR. This is a prospective study aimed at determining the common causes of sudden deaths in young adults. Early analysis of data from the study indicates that heart attacks, or myocardial infarction (MI), continue to be the leading cause of sudden death in this age group. Importantly, no major changes in the pattern of causes have been observed when compared with previous years. In the majority of the unexplained death cases, genetic mutations have been identified as a possible cause of these deaths. The final results will be shared once the study is complete, said the statement.

“Together, these two studies offer a more comprehensive understanding of sudden unexplained deaths in young adults in India. It has also been revealed that COVID-19 vaccination does not appear to increase the risk, whereas, the role of underlying health issues, genetic predisposition and risky lifestyle choices does play a role in unexplained sudden deaths.”

Scientific experts have reiterated that statements linking Covid vaccination to sudden deaths are false and misleading, and are not supported by scientific consensus. Speculative claims without conclusive evidence risk undermining public confidence in vaccines, which have played a crucial role in saving millions of lives during the pandemic.

“Such unfounded reports and claims could strongly contribute to vaccine hesitancy in the country, thereby adversely impacting public health. The Government of India remains committed to evidence-based public health research to protect the well-being of its citizens,” read the statement.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More

Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.